EVOK - Evoke Pharma Inc. (EVOK) CEO Dave Gonyer on Q4 2021 Results - Earnings Call Transcript

Evoke Pharma, Inc. (EVOK) Q4 2021 Earnings Conference Call March 8, 2022, 4:30 PM ET Company Participants Dave Gonyer – Chief Executive Officer Matt D’Onfrio – Chief Business Officer Chris Quesenberry – Gimoti’s Chief Commercial Officer from EVERSANA Conference Call Participants Yale Jen – Laidlaw Mitchell Kapoor – Wainwright Presentation Operator Gentlemen, today's conference will resume momentarily. Please hold. And we now have today's management on the call. Please go ahead. Daniel Kontoh-Boateng Good afternoon and thank you for participating in Evoke's Pharma's conference call today. With me today are Dave Gonyer, Evoke's Chief Executive Officer, Chris Quesenberry, Gimoti's Chief Commercial Officer from EVERSANA, and Matt D'Onofrio, Evoke's Chief Business Officer. By now, you should have a copy of the press release we issued earlier, if not it is available on the Investor Relations page of our website at evokepharma.com. We encourage everyone to read today's press release as well

For further details see:

Evoke Pharma, Inc. (EVOK) CEO Dave Gonyer on Q4 2021 Results - Earnings Call Transcript